RoC Skincare is recruiting 30 pairs of adult female identical twins aged 40 and older in the US for a 12-week study that combines its Patented Clinical Retinol regimen with clinical skin measurements and wearable lifestyle tracking. The move follows a pilot study that the company says was designed to test whether identical twins could provide a more precise model for studying visible skin aging.
Art Pellegrino, RoC’s chief scientific officer, said the pilot was mainly intended to validate whether identical twins could offer a clearer way to study what drives visible skin aging. He said the answer was yes. The company is now applying that model to a focused group as part of a longer research program on extending the period in which skin looks its best.
Identical twins share DNA and much of their early environment. RoC argues that when their skin ages differently, lifestyle and environment become more likely explanations than genetics. Pellegrino said this setup makes it easier to see what the retinol is doing on the skin because differences are harder to attribute to genetic variation.
Pilot findings and limits
In the pilot, Pellegrino said twins in the placebo group had similar or worse signs of aging at the end of the study, while twins in the treatment group showed as much as or more than 20% improvement in four weeks. Those are company-reported findings from the pilot, not results from the expanded 12-week study.
The pilot did not attempt to measure how much skin aging comes from genes versus lifestyle, Pellegrino said. The expanded study is intended to examine that question, including how daily factors such as sleep and stress change the picture when genetics are held constant.
Wearables and clinical measures
Participants are asked to wear an Oura Ring, a wearable device that tracks health and wellness metrics, to capture variations in sleep, stress, heart rate, heart rate variability and temperature trends. RoC’s clinical skin measures include expert grading, digital photography, corneometer readings and participant self-assessment.
Pellegrino said wearables are creating an opportunity to factor how people live into skin care recommendations. Because RoC cannot guarantee that twins have identical external influences such as sun exposure or diet, the company is recruiting twins with similar levels of environmental damage where possible and tracking sleep and stress throughout the study.
The company expects the combination to help quantify external stressors and their impact on skin condition. If one twin sleeps poorly or reports more stress, researchers can compare whether her skin responds differently to the regimen than her sister’s, Pellegrino said. RoC expects results from the twin study by mid-2027, and says the findings will shape future product development and clinical study design.
